3,926
Views
21
CrossRef citations to date
0
Altmetric
Special Section: Management of automation and advanced manufacturing technology (AAMT) in the context of global manufacturing

Reconfiguring global pharmaceutical value networks through targeted technology interventions

, &
Pages 1471-1487 | Received 02 Dec 2015, Accepted 29 Jul 2016, Published online: 18 Aug 2016

References

  • Adner, R., and R. Kapoor. 2010. “Value Creation in Innovation Ecosystems: How the Structure of Technological Interdependence Affects Firm Performance in New Technology Generations.” Strategic Management Journal 31 (3): 306–333. doi:10.1002/smj.821.
  • Ariss, S. S., T. S. Raghunathan, and A. Kunnathar. 2002. “Factors Affecting the Adoption of Advanced Manufacturing Technology in Small Firms.” SAM Advanced Management Journal 65 (2): 14–23.
  • Avorn, J. 2014. “The $2.6 Billion Pill: Methodologic and Policy Considerations.” New England Journal of Medicine 372: 1877–1879. doi:10.1056/NEJMp1500848.
  • Ayre, C., and A. J. Scally. 2014. “Critical Values for Lawshe’s Content Validity Ratio: Revisiting the Original Methods of Calculation.” Measurement and Evaluation in Counseling and Development 47 (1): 79–86. doi:10.1177/0748175613513808.
  • Brown, C. J., Y. C. Lee, Z. K. Nagy, and X. Ni. 2014. “Evaluation of Crystallization Kinetics of Adipic Acid in an Oscillatory Baffled Crystallizer.” Crystal Engineering Communications 16 (34): 8008–8014. doi:10.1039/c4ce00192c.
  • Callahan, C. J., and X.-W. Ni. 2014. “An Investigation into the Effect of Mixing on the Secondary Nucleation of Sodium Chlorate in a Stirred Tank and an Oscillatory Baffled Crystallizer.” Crystal Engineering Communications 16 (4): 690–697. doi:10.1039/c3ce41467a.
  • Chan, F. T. S., M. H. Chan, H. Lau, and R. W. L. Ip. 2001. “Investment Appraisal Techniques for Advanced Manufacturing Technology (AMT): A Literature Review.” Integrated Manufacturing Systems 12 (1): 35–47. doi:10.1108/09576060110361528.
  • CMAC. 2014. CMAC Annual Report. http://www.cmac.ac.uk/files/media/cmac_brochure_2014.pdf.
  • Daly, R., T. S. Harrington, G. D. Martin, and I. M. Hutchings. 2015. “Inkjet Printing for Pharmaceutics - A Review of Research and Manufacturing.” International Journal of Pharmaceutics 494 (2): 554–567. doi:10.1016/j.ijpharm.2015.03.017.
  • DiMasi, J. A. 2002. “The Value of Improving the Productivity of the Drug Development Process.” PharmacoEconomics 20 (Supplement 3): 1–10.10.2165/00019053-200220003-00001
  • DiMasi, J. A., R. W. Hansen, and H. G. Grabowski. 2003. “The Price of Innovation: New Estimates of Drug Development Costs.” Journal of Health Economics 22: 151–185. doi:10.1016/S0167-6296(02)00126-1.
  • DiMasi, J. A., H. G. Grabowski, and R. W. Hansen. 2016. “Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs.” Journal of Health Economics 47: 20–33. doi:10.1016/j.jhealeco.2016.01.012.
  • Dixon, J., P. England, G. Lawton, P. Machin, and A. Palmer. 2010. “Medicines Discovery in the 21st Century: The Case for a Stakeholder Corporation.” Drug Discovery Today 15 (17–18): 700–703. doi:10.1016/j.drudis.2010.07.004.
  • Edwards, P. J. 2009. “Value Networks Identify Innovation in 21st Century Pharmaceutical Research.” Drug Discovery Today 14 (1-2): 68–77. doi:10.1016/j.drudis.2008.09.015.
  • Eisenhardt, K. M., and M. E. Graebner. 2007. “Theory Building From Cases: Opportunities and Challenges.” Academy of Management Journal 50 (1): 25–32. doi:10.5465/AMJ.2007.24160888.
  • Erhard, A., J. Anscombe, G. Ortolani, T. Wintermantel, and E. de Bres-Riemslag. 2013. Building Value-based Healthcare Business Models. Munich: AT Kearney.
  • Farooq, S., and C. O’Brien. 2012. “A Technology Selection Framework for Integrating Manufacturing within a Supply Chain.” International Journal of Production Research 50 (11): 2987–3010. doi:10.1080/00207543.2011.588265.
  • Goyal, S., and S. Grover. 2012. “Advanced Manufacturing Technology Effectiveness: A Review of Literature and Some Issues.” Frontiers of Mechanical Engineering 7 (3): 256–267. doi:10.1007/s11465-012-0330-7.
  • Gunawardana, K. D. 2006. “Introduction of Advanced Manufacturing Technology: A Literature Review.” Sabaragamuwa University Journal 6 (1): 116–134.
  • Harrington, T. S., and J. S. Srai. 2012. “Defining Product-service Network Configurations and Location Roles: A Current and Future State Analysis Framework for International Engineering Operations.” International Journal of Product Development 17 (3/4): 228–253. doi:10.1504/IJPD.2012.052103.
  • Harrington, T. S., and J. S. Srai. 2016. “Understanding Stages of Supply Network Emergence in Technology Commercialisation.” International Journal of Manufacturing Technology and Management. doi:10.1504/IJMTM.2016.10000001.
  • Harrington, T. S., J. S. Srai, M. Kumar, and J. Wohlrab. 2016. “Identifying Design Criteria for Urban System ‘Last-mile’ Solutions – A Multi-stakeholder Perspective.” Production Planning and Control 27 (6): 456–476. doi:10.1080/09537287.2016.1147099.
  • Hay, M., D. W. Thomas, J. L. Craighead, C. Economides, and J. Rosenthal. 2014. “Clinical Development Success Rates for Investigational Drugs.” Nature Biotechnology 32: 40–51. doi:10.1038/nbt.2786.
  • Jacobides, M. G. 2005. “Industry Change Through Vertical Disintegration: How and Why Markets Emerged in Mortgage Banking.” Academy of Management Journal 48 (3): 465–498. doi:10.5465/AMJ.2005.17407912.
  • Laird, T. 2013. “Special Feature Section: Polymorphism and Crystallisation.” Organic Process Research and Development 17: 443–444. doi:10.1021/op4000303.
  • Leyshon, A. 2001. “Time–Space (and Digital) Compression: Software Formats, Musical Networks, and the Reorganisation of the Music Industry.” Environment and Planning A 33: 49–77. doi:10.1068/a3360.
  • McGlone, T., N. Briggs, C. Clark, C. Brown, J. Sefcik, and A. J. Florence. 2015. “Oscillatory Flow Reactors (OFRs) for Continuous Manufacturing and Crystallization.” Organic Process Research and Development 19 (9): 1186–1202. doi:10.1021/acs.oprd.5b00225.
  • Nair, A., and W. R. Boulton. 2008. “Innovation-oriented Operations Strategy Typology and Stage-based Model.” International Journal of Operations and Production Management 28 (8): 748–771. doi:10.1108/01443570810888599.
  • Powell, K. A., A. N. Saleemi, C. D. Rielly, and Z. K. Nagy. 2015. “Periodic Steady-state Flow Crystallization of a Pharmaceutical Drug Using MSMPR Operation.” Chemical Engineering and Processing: Process Intensification 97: 195–212. doi:10.1016/j.cep.2015.01.002.
  • Powell, K. A., A. N. Saleemi, C. D. Rielly, and Z. K. Nagy. 2016. “Monitoring Continuous Crystallization of Paracetamol in the Presence of an Additive Using an Integrated PAT Array and Multivariate Methods.” Organic Process Research and Development 20 (3): 626–636. doi:10.1021/acs.oprd.5b00373.
  • RAE (Royal Academy of Engineering). 2012. Industrial Systems: Capturing Value through Manufacturing. London: RAE. ISBN 1-903496-69-1.
  • Rantanen, J., and J. Khinast. 2015. “The Future of Pharmaceutical Manufacturing Sciences.” Journal of Pharmaceutical Sciences 104 (11): 3612–3638. doi:10.1002/jps.24594.
  • Saberi, S., and R. M. Yusuff. 2012. “Neural Network Application in Predicting Advanced Manufacturing Technology Implementation Performance.” Neural Computing and Applications 21 (6): 1191–1204. doi:10.1007/s00521-010-0507-0.
  • Sarasvathy, S. D., and N. Dew. 2005. “New Market Creation through Transformation.” Journal of Evolutionary Economics 15 (5): 533–565. doi:10.1007/s00191-005-0264-x.
  • Sebastiao, H., and S. Golicic. 2008. “Supply Chain Strategy for Nascent Firms in Emerging Technology Markets.” Journal of Business Logistics 29 (1): 75–91. doi:10.1002/j.2158-1592.2008.tb00069.x.
  • Shah, N. 2004. “Pharmaceutical Supply Chains: Key Issues and Strategies for Optimization.” Computers and Chemical Engineering 28: 929–41. doi:10.1016/j.compchemeng.2003.09.022.
  • Srai, J. S., and L. S. Alinaghian. 2013. “Value Chain Reconfiguration in Highly Disaggregated Industrial Systems: Examining the Emergence of Health Care Diagnostics.” Global Strategy Journal 3: 88–108. doi:10.1111/j.2042-5805.2012.01047.x.
  • Srai, J. S., and M. Gregory. 2008. “A Supply Network Configuration Perspective on International Supply Chain Development.” International Journal of Operations and Production Management 28 (5): 386–411. doi:10.1108/01443570810867178.
  • Srai, J. S., C. Badman, M. Krumme, M. Futran, and C. Johnston. 2015. “Future Supply Chains Enabled by Continuous Processing—Opportunities Challenges May 20–21 2014 Continuous Manufacturing Symposium.” Journal of Pharmaceutical Sciences 104 (3): 840–849. doi:10.1002/jps.24343.
  • Srai, J. S., T. S. Harrington, L. A. Alinaghian, and M. A. Phillips. 2015. “Evaluating the Potential for the Continuous Processing of Pharmaceutical Products – A Supply Network Perspective.” Chemical Engineering and Processing: Process Intensification 97: 248–258. doi:10.1016/j.cep.2015.07.018.
  • Variankaval, N., A. S. Cote, and M. F. Doherty. 2008. “From Form to Function: Crystallization of Active Pharmaceutical Ingredients.” AIChE Journal 54 (7): 1682–1688. doi:10.1002/aic.11555.
  • Voelpel, S. C., M. Leibold, and E. B. Tekie. 2004. “The Wheel of Business Model Reinvention: How to Reshape Your Business Model to Leapfrog Competitors.” Journal of Change Management 4 (3): 259–276. doi:10.1080/1469701042000212669.
  • Yin, R. K. 2009. Case Study Research: Design and Methods. 4th ed. Thousand Oaks, CA: Sage.
  • Zahra, S. A., and A. P. Nielsen. 2002. “Sources of Capabilities, Integration and Technology Commercialization.” Strategic Management Journal 23 (5): 377–398. doi:10.1002/smj.229.
  • Zhang, Y., and M. Gregory. 2011. “Managing Global Network Operations along the Engineering Value Chain.” International Journal of Operations and Production Management 31 (7): 736–764. doi:10.1108/01443571111144832.